FINNENCE ▪ THE WIRE FILE
THE WIRE · № 61713
News■ Mixed
Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
KINDNews
DIRECTION■ Mixed
SOURCES1
ENTITIES4
STORY SIZESTANDALONE
FIRST SEEN2026-10-02 11:18 UTC
LAST UPDATE2026-10-02 11:18 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Patent-cliff pressure pushes pharma to license Chinese assets, shifting R&D value toward China biotech.
Big Pharma increasingly sources innovation from China
CATALYST TO WATCH
Announced licensing deals or trial data
MAIN RISK
Regulatory or geopolitical deal friction
FULL DISPATCH
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike2026-10-02 10:57 UTC
4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike2026-10-02 10:57 UTC
→CORRELATIONshares Healthcare
Afya (AFYA) Stock Looks Cheap Following A Fresh Merger Agreement2026-10-02 11:45 UTC
Afya (AFYA) Stock Looks Cheap Following A Fresh Merger Agreement2026-10-02 11:45 UTC
→CORRELATIONshares China
EXCLUSIVE: China demands copper supply commitments for Anglo Teck merger approval, sources say2026-10-02 12:04 UTC
EXCLUSIVE: China demands copper supply commitments for Anglo Teck merger approval, sources say2026-10-02 12:04 UTC
→CORRELATIONshares Healthcare, LLY
OAC Calls on Cigna to Listen to Employees and Restore GLP-1 Coverage2026-10-02 12:15 UTC
OAC Calls on Cigna to Listen to Employees and Restore GLP-1 Coverage2026-10-02 12:15 UTC
→CORRELATIONshares China
Ukraine war: Japan’s new sanctions on Russia target oil exports2026-10-02 12:30 UTC
Ukraine war: Japan’s new sanctions on Russia target oil exports2026-10-02 12:30 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.